Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use
Ito, Satoru, Otsuki, Sachie, Ohsawa, Hirokazu, Hirano, Atsushi, Kazuno, Hideki, Yamashita, Satoshi, Egami, Kosuke, Shibata, Yoshihiro, Yamamiya, Ikuo, Yamashita, Fumiaki, Kodama, Yasuo, Funabashi, Kaoru, Kazuno, Hiromi, Komori, Toshiharu, Suzuki, Satoshi, Sootome, Hiroshi, Hirai, Hiroshi, Sagara, Takeshi
Published in ACS medicinal chemistry letters (13.04.2023)
Published in ACS medicinal chemistry letters (13.04.2023)
Get full text
Journal Article
The novel VEGF receptor/MET-targeted kinase inhibitor TAS-115 has marked in vivo antitumor properties and a favorable tolerability profile
Fujita, Hidenori, Miyadera, Kazutaka, Kato, Masanori, Fujioka, Yayoi, Ochiiwa, Hiroaki, Huang, Jinhong, Ito, Kimihiro, Aoyagi, Yoshimi, Takenaka, Toru, Suzuki, Takamasa, Ito, Satoko, Hashimoto, Akihiro, Suefuji, Takashi, Egami, Kosuke, Kazuno, Hideki, Suda, Yoshimitsu, Nishio, Kazuto, Yonekura, Kazuhiko
Published in Molecular cancer therapeutics (01.12.2013)
Published in Molecular cancer therapeutics (01.12.2013)
Get full text
Journal Article
Abstract A245: TAS-115, a novel potent dual MET/VEGFRs inhibitor, has highly safer profile leading to more potent efficacy in vivo
Kato, Masanori, Fujita, Hidenori, Miyadera, Kazutaka, Fujioka, Yayoi, Ochiiwa, Hiroaki, Huang, Jinhong, Ito, Kimihiro, Aoyagi, Yoshimi, Takenaka, Toru, Suzuki, Takamasa, Ito, Satoko, Hashimoto, Akihiro, Suefuji, Takashi, Sato, Ayako, Egami, Kosuke, Kazuno, Hideki, Suda, Yoshimitsu, Yonekura, Kazuhiko
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article